> top > docs > PMC:7195088 > spans > 66201-66604 > annotations

PMC:7195088 / 66201-66604 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1895 168-176 Species denotes patients Tax:9606
1900 182-190 Disease denotes COVID-19 MESH:C000657245
1925 15-25 Species denotes SARS-CoV-2 Tax:2697049
1928 86-93 Chemical denotes LPV/RTV MESH:C558899
1929 157-164 Chemical denotes LPV/RTV MESH:C558899

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T380 15-23 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T381 182-190 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T367 306-308 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T368 399-401 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T94861 341-345 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T469 0-403 Sentence denotes With regard to SARS-CoV-2, although the results of the previously cited RCT comparing LPV/RTV versus standard of care eventually does not support the use of LPV/RTV in patients with COVID-19, it is also of note that the median time between symptom onset and randomization was 13 days (interquartile range, 11–16 days), so in most cases, the drug was initiated late during the course of the disease [22].

2_test

Id Subject Object Predicate Lexical cue
32360444-32187464-22369823 399-401 32187464 denotes 22